Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUMATRIPTAN vs SUVOREXANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUMATRIPTAN vs SUVOREXANT: Safety Overview

Metric SUMATRIPTAN SUVOREXANT
Total FAERS Reports 17,442 9,413
Deaths Reported 305 219
Death Rate 1.7% 2.3%
Hospitalizations 1,580 572
Average Patient Age 45.7 yrs 62.6 yrs
% Female Patients 84.9% 62.4%
FDA Approval Date Apr 14, 2014 Aug 13, 2014
Manufacturer Sun Pharmaceutical Industries, Inc. Merck Sharp & Dohme LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription